Globus Medical Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Globus Medical hat ein Gesamteigenkapital von $4.1B und eine Gesamtverschuldung von $437.1M, wodurch sich der Verschuldungsgrad auf 10.7% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $5.1B bzw. $1.0B. Globus Medical Das EBIT des Unternehmens beträgt $395.0M, so dass der Zinsdeckungsgrad 52.1 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $694.7M.

Wichtige Informationen

10.7%

Verhältnis von Schulden zu Eigenkapital

US$437.14m

Verschuldung

Zinsdeckungsgrad52.1x
BargeldUS$694.71m
EigenkapitalUS$4.07b
GesamtverbindlichkeitenUS$1.02b
GesamtvermögenUS$5.09b

Jüngste Berichte zur Finanzlage

Recent updates

Globus Medical Stock: Re-Rated After A Solid Year

Nov 18

Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Nov 04
Globus Medical (NYSE:GMED) Has A Rock Solid Balance Sheet

Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Oct 14
Globus Medical, Inc.'s (NYSE:GMED) Shareholders Might Be Looking For Exit

Globus Medical: A Post Acquisition Analysis

Aug 26

Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

Jun 28
Globus Medical, Inc.'s (NYSE:GMED) Earnings Haven't Escaped The Attention Of Investors

An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Apr 08
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued

Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Mar 20
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly

Globus Medical Q4: Greater Dis-Synergies Hold Back The Stock

Feb 27

Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Feb 09
Is Now An Opportune Moment To Examine Globus Medical, Inc. (NYSE:GMED)?

Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Jan 17
Globus Medical, Inc.'s (NYSE:GMED) Price In Tune With Earnings

Globus Medical: Merger Overhang Lingering

Nov 27

Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Nov 14
Does Globus Medical (NYSE:GMED) Have A Healthy Balance Sheet?

Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Oct 27
Should You Investigate Globus Medical, Inc. (NYSE:GMED) At US$46.27?

Globus Medical: Almost Having My Back

Sep 13

Globus Medical: Slightly Too Pricey Right Now

Aug 07

Globus Medical: Robotics Demand Ratcheting Higher, Reiterate Buy

Jul 18

Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Jul 11
Should You Think About Buying Globus Medical, Inc. (NYSE:GMED) Now?

Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Jun 18
Here's Why We Think Globus Medical (NYSE:GMED) Is Well Worth Watching

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Apr 09
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Mar 22
What Is Globus Medical, Inc.'s (NYSE:GMED) Share Price Doing?

Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Feb 24
Do Globus Medical's (NYSE:GMED) Earnings Warrant Your Attention?

Globus Medical Q4 2022 Earnings Preview

Feb 20

Globus Medical: An Impressive Long-Term Revenue Growth Play

Jan 08

Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Dec 22
Is It Too Late To Consider Buying Globus Medical, Inc. (NYSE:GMED)?

Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Dec 01
Globus Medical (NYSE:GMED) Will Want To Turn Around Its Return Trends

Globus Medical Non-GAAP EPS of $0.50 misses by $0.02, revenue of $254.15M in-line

Nov 08

A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Oct 15
A Look At The Fair Value Of Globus Medical, Inc. (NYSE:GMED)

Globus Medical: Compelling Long-Term Value On Offer, Buy Thesis Intact

Sep 02

Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Sep 02
Globus Medical (NYSE:GMED) Will Be Hoping To Turn Its Returns On Capital Around

Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Aug 11
Is Globus Medical, Inc. (NYSE:GMED) Potentially Undervalued?

Globus Medical: Low Rates Sensitivity, Seeking 26% Return Objective

Jun 05

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: GMEDDie kurzfristigen Aktiva des Unternehmens ($2.1B) übersteigen seine kurzfristigen Passiva ($818.1M).

Langfristige Verbindlichkeiten: GMEDDie kurzfristigen Vermögenswerte des Unternehmens ($2.1B) übersteigen seine langfristigen Verbindlichkeiten ($198.6M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: GMED über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: GMEDDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 10.7% gestiegen.

Schuldendeckung: GMEDDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (94.9%).

Zinsdeckung: GMEDDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (52.1x Coverage) gut gedeckt.


Bilanz


Entdecken Sie finanziell stabile Unternehmen